A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation

• Status: Completed
• Trial end date: 2004-05-01

Summary

To demonstrate the comparative safety and efficacy of Cetrotide® 3 milligram (mg) and Antagon™ in the inhibition of a premature luteinizing hormone (LH) surge in women undergoing ovarian stimulation with recombinant human follicle stimulating hormone/human menopausal gonadotropin (r-hFSH/hMG) prior to assisted reproductive technology (ART) and utilizing oral contraceptives pill (OCP) for cycle programming.

• Phase: Phase 4

Details

• Lead Sponsor: EMD Serono
• Treatments: Cetrorelix; Chorionic Gonadotropin; Follicle Stimulating Hormone; Ganirelix; Hormones; Menotropins